Eisai obesity drug Belviq may have an edge with new heart safety data—but to what end?

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jul 18, 2018 at 11:12 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via More than six years after winning approval, obesity drug Belviq has shown it’s heart safe. But whether that claim can jump-start sales in an ice-cold market remains to be seen.

    article source